UK Companies House feature
SHIELD THERAPEUTICS PLC
Profile
- Company number
- 09761509
- Status
- Active
- Incorporation
- 2015-09-03
- Last accounts made up
- 2024-12-31
- Account category
- GROUP
- Primary SIC
- 86900
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- UK-adopted IFRS
- Reporting scope
- Consolidated (group)
- Auditor
- Crowe U.K. LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on the above factors, the Directors believe that it remains appropriate to prepare the financial statements on a going concern basis.”
Subsidiaries
- Phosphate Therapeutics Limited · 1% held · United Kingdom
- Shield TX (Switzerland) AG · 1% held · Switzerland
- Shield Therapeutics Inc · 1% held · U.S.
- Shield TX (UK) Limited · 1% held · United Kingdom
Significant events
- “153% year-on-year growth in U.S. ACCRUFER® revenues”
- “c.$31M in financings”
- “Health Canada approval”
- “Succesful pediatric trial (Phase 3) in ID/IDA”
- “Regulatory submission in South Korea and fully recruited Phase 3 trial in China”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
7 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HUNTINGTON-BAILEY, Lucy Kate | Secretary | 2017-09-01 | — | — |
| HASLER, Hans Peter | Director | 2018-07-26 | Feb 1956 | Swiss |
| LACERCA-ALLEN, Maria Fabiana | Director | 2021-05-10 | Apr 1967 | Argentine,American |
| LLEWELLYN-DAVIES, Peter | Director | 2016-02-26 | Apr 1958 | British |
| LUNDSTROM, Karl Anders | Director | 2021-05-10 | May 1962 | Swedish,American |
| SCHWEIGER, Christian Karl Kurt, Dr | Director | 2020-06-26 | Jul 1966 | German,Swiss |
| WIDMANN, Rudolf Stefan, Dr | Director | 2024-07-03 | Mar 1957 | Austrian |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| JONES, Richard | Secretary | 2015-09-03 | 2017-01-27 |
| CAPITA REGISTRARS LIMITED | Corporate Secretary | 2017-01-27 | 2017-09-01 |
| ESTELL, Joanne Elizabeth | Director | 2017-05-01 | 2017-09-14 |
| HEATH, Andrew John William | Director | 2016-02-26 | 2018-06-27 |
| HOFFMANN, Rolf Karl Heinz | Director | 2018-04-06 | 2021-06-17 |
| JONES, Richard Crispin Morgan | Director | 2015-09-03 | 2017-01-27 |
| KARIS, James | Director | 2016-02-26 | 2020-06-18 |
| MADISON, Gregory Paul | Director | 2021-06-18 | 2024-07-24 |
| STERRITT, Carl Andrew | Director | 2015-09-03 | 2020-04-21 |
| WATTS, Tim William | Director | 2020-04-27 | 2021-09-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Aop Health International Management Ag | Corporate entity | Shares 25–50%, Voting 25–50% | 2022-08-01 | Active |
| Nestle Sa | Corporate entity | Shares 25–50%, Voting 25–50% | 2017-06-26 | Ceased 2022-09-01 |
Filing timeline
Last 20 of 124 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-02-20 | SH01 | capital | capital allotment shares |
| 2026-01-29 | SH01 | capital | capital allotment shares |
| 2026-01-27 | SH01 | capital | capital allotment shares |
| 2025-12-17 | SH01 | capital | capital allotment shares |
| 2025-09-26 | SH01 | capital | capital allotment shares |
| 2025-09-26 | SH01 | capital | capital allotment shares |
| 2025-09-04 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-06-12 | RESOLUTIONS | resolution | resolution |
| 2025-06-06 | AA | accounts | accounts with accounts type group |
| 2025-01-06 | RESOLUTIONS | resolution | resolution |
| 2025-01-02 | SH01 | capital | capital allotment shares |
| 2024-09-02 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-08-05 | TM01 | officers | termination director company with name termination date |
| 2024-07-12 | AP01 | officers | appoint person director company with name date |
| 2024-06-27 | RESOLUTIONS | resolution | resolution |
| 2024-06-17 | AA | accounts | accounts with accounts type group |
| 2023-10-20 | SH01 | capital | capital allotment shares |
| 2023-10-09 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2023-10-09 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2023-09-04 | CS01 | confirmation-statement | confirmation statement with no updates |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.